Abstract
Bisphosphonates are widely used for treatment of postmenopausal osteoporosis. Patients with primary biliary cirrhosis often have osteoporosis - either postmenopausal or secondary to the liver disease. No systematic review or meta-analysis has assessed the effects of bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.
Original language | English |
---|---|
Journal | Cochrane Database of Systematic Reviews |
Volume | 12 |
Pages (from-to) | CD009144 |
ISSN | 1469-493X |
DOIs | |
Publication status | Published - 2011 |